“When I remind people outside the medical community that we’ve seen a 34% decline in cancer mortality since 1991, they are genuinely shocked... We don't have a science problem in the U.S.—but we do have a translation problem." What an incredibly powerful insight from @DrKarenKnudsen of the @parkerici (PICI) during our latest episode of the RadOnc Report. I recently sat down with Dr. Knudsen and Dr. Vivek Kavadi, CEO of @ASTRO_org to discuss the accelerating synergy between radiotherapy and immunotherapy, and how radiation can function as an "in vivo vaccination" to reshape the tumor microenvironment. We also explored PICI’s innovative acceleration models, and why communicating our scientific victories is just as critical as the science itself. This is exactly why our theme for the 2026 ASTRO Annual Meeting is "Data to Dialogue." Generating evidence is not enough; we must bridge the gap between generating evidence and ensuring our patients, colleagues and policymakers truly understand its impact. 🎧 to the RadOnc Report ⬇️ Spotify: bit.ly/4gfXhi4 Online bit.ly/4yawds7 We will be continuing the dialogue at the #ASTRO26 Presidential Symposium in Boston. If you want to be at the forefront of patient care and innovation, consider attending and being part of the conversation! #RadOnc #Immunotherapy #CancerResearch

It was an absolute pleasure to chat with @mcuban about a broad range of topics, from the challenges affecting #healthcare to drug pricing innovation, AI & defining value in #oncology. Always appreciate your fresh perspective, Mark - thank you for sharing it with our Radiation Oncology community!